Purpose: Cytokines and hormones derived from adipose tissue are implicated in bone metabolism and atherogenesis. There is little data on the relationship between serum omentin-1 and vascular disease. We aimed to investigate the relationship between levels of serum omentin-1 and bone profile parameters in Saudi postmenopausal females with and without subclinical atherosclerosis.
Introduction
Omentin is an adipokine, that is predominantly Omentin-1 has also been shown to have a potentially protective effect in the cardiovascular system by inhibiting osteoblastic differentiation of cardiovascular smooth muscle cells via PI3K/Akt signaling pathway [6] . The latter is associated with the expression of genes associated with calcification within atherosclerotic plaque, and hence with plaque inflammation and instability.
Postmenopausal women are at increased risk of cardiovascular disease with the cessation of estrogen production, which is thought to both protect the vascular endothelium and affect lipoprotein metabolism. In addition to the well-known classical cardiovascular risk factors, some novel risk factors such as chronic lowgrade inflammation and bone metabolism regulators are increasingly thought to have a role [7] .
Epidemiologic studies have also reported inverse associations between bone mineral density (BMD) and calcified atherosclerosis, independent age, sex, race/ ethnicity, cigarette smoking, and physical activity [8] [9] [10] . A leading explanation for the inverse association of BMD with calcified atherosclerosis implicates adipokines.
Carotid intima-media thickness (CIMT) has been proposed as a marker of early atherosclerosis and a predictor of future vascular events [11] . An increased CIMT is associated with several classical cardiovascular risk factors [12] , increases in women significantly after the menopause, and is positively associated with the presence of classical cardiovascular risk factors [13] .
The objective of the current study was to investigate the relationship between circulating levels of serum omentin-1 and bone profile parameters in Saudi postmenopausal women, with and without subclinical carotid atherosclerosis, as determined by CIMT.
Methods
One hundred and twenty-six postmenopausal women, aged 50-72 years, were enrolled in this case-control study. They were selected sequentially from the Internal Medicine department of the King Abdulaziz University Hospital (KAUH), Jeddah, KSA.
Postmenopausal status was defined as the period of time after a woman has experienced 12 consecutive months without menstruation. The study was approved by the Ethical Committee of the KAUH.
All subjects were interviewed to complete a detailed questionnaire, comprising demographic and medical history and underwent a physical examination. The following exclusion criteria were used: 1) the presence of generalized bone disease including hyperparathyroidism, hypoparathyroidism, thyroid disorders, rheumatoid arthritis, Cushing disease, and steroid-induced osteoporosis, or renal osteodystrophy;
2) the presence of cardiovascular disease, including coronary artery disease, acute myocardial infarction, peripheral vascular disease, or stroke;
3) a history of malignant disease, type 1 diabetes mellitus, and liver diseases; and 4) any subject receiving supplements or treatment that might influence bone metabolism (e.g., calcium, corticosteroids, vitamin D, calcitonin, bisphonates, anti-vitamin K agents, diuretics, or β-blockers, hormone replacement therapy).
Height and weight were measured using a stadiometer and a standardized balance-beam scales respectively. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters. Abdominal circumference was measured in centimeters at the midpoint between the lowest rib and the top of the iliac crest. The waist-to-hip ratio (WHR) was calculated as the ratio of waist/hip circumference. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in the seated position after 5 minutes rest.
All patients were examined ultrasonographically using high resolution B-mode device with a 10 MHz linear array transducer (iU22 xMatrix ultrasound system, Philips Medical Systems, USA). CIMT was measured using B-mode ultrasound imaging of the carotid artery, in the longitudinal axis, at the level of the far wall of common carotid artery free of plaque, 1 cm before bifurcation. The measurement followed a standardized scanning protocol [14] .
The mean values of maximum left and right common carotid arteries were determined. Common, internal and external carotid arteries on both sides were subsequently scanned and the presence of plaques was noted. A plaque was defined as a focal wall region with CIMT ≥ 0.9 mm that protrudes into the lumen [15] . The presence of carotid stenosis was assessed using echo-Doppler accepted criteria [16] .
Blood samples were collected after an overnight fast. Serum was separated from the blood corpuscles by centrifugation at 5000 g for 10 min and kept frozen at -80 o C until the time of the analysis.
Standard laboratory techniques were used to determine serum calcium, albumin and bonespecific alkaline phosphatase (ALP). An enzyme chemiluminescence assay (Immundiagnostik, Bensheim and Biomedica, Wien) was used for the measurement of 25-hydroxy vitamin D. The mean intraassay and inter-assay CVs of the 25-OH vitamin D assay were 5.7% and 10.2%, respectively. Serum omentin-1 was measured by enzyme-linked immunosorbent assay (ELISA) technique (BioVendor, LLC Candler, North Carolina, USA), with 3.6% intraassay variation and 8.4% inter-assay variation.
Data are presented as mean ± Standard Error of Mean for numeric variables and as number (percentage) for categoric variables. Comparisons of continuous variables between groups were performed by MannWhitney U and chi square tests for numeric and categorical variables respectively. The relationships of serum omentin-1 concentrations with other variables were evaluated by Pearson or Spearman coefficient correlation for parametric and nonparametric variables respectively. Multivariate linear stepwise analysis was performed to determine how much of the variance in omentin-1 level could be explained by variables with significant correlations in univariate analysis. A p-value < 0.05 was considered statistically significant in all statistical analyses. The Statistical Package for the Social Sciences (SPSS) software version 20.0 was used. Table 1 summarizes socio-demographic parameters of 126 postmenopausal women with and without subclinical carotid atherosclerosis. No statistical difference was noted between both groups except for significantly higher SBP readings among cases with subclinical carotid atherosclerosis as compared with their age-matched controls (p<0.05). Physical inactivity was more prevalent among the controls who also had a higher annual income and educational attainment compared to the case group (p<0.05).
Results
Serum omentin-1 levels were significantly higher among postmenopausal women with subclinical carotid atherosclerosis than their age-matched controls (p<0.05) as shown in Figure 1 .
No significant differences were found between the groups in terms of bone profile parameters (p>0.05) as shown in Table 1 . Furthermore, vitamin D deficiency was highly prevalent among the study population (88% of cases and 90% of controls respectively).
As illustrated in Figure 2 , omentin-1 was positively correlated with CIMT (r=0.287, p<0.01). Notably, as presented in Table 2 , serum omentin-1 was also correlated with age, weight, BMI and WHR.
In multiple stepwise regression analysis, mean CIMT (β=0.265, p<0.01, 95% CI 104.28: 466.8) and body weight (β=-0.195, p<0.05, 95% CI -5.028: -0.364) were independently associated with serum omentin-1 concentrations (Table 3) .
Discussion
Previous studies have described various cytokines that are implicated in bone and adipose tissue crosstalk [17, 18] .
It is hypothesized that omentin-1 inhibits bone formation associated with bone loss in premenopausal women [5] . Nonetheless, the role of omentin-1 in bone metabolism has not been investigated among postmenopausal women with subclinical carotid atherosclerotic disease. It is well known that sex hormones play an important role in the regulation of bone metabolism [19] .
In the current study, serum vitamin D and bone-specific ALP activity levels were not-significantly different among postmenopausal women with subclinical carotid atherosclerosis as compared with their age-matched controls. Recent studies have shown that omentin-1 can inhibit osteoblast differentiation in vitro [3, 20] . Bonespecific serum ALP concentrations, is used as a marker of bone formation, but this failed to show any significant relationship with serum omention-1 levels in the current study cohort (r= -0.211, p=0.065), although this may be due to the relatively small sample size (n=126).
Our data showed that serum omentin-1 levels were negatively correlated with body weight and BMI levels. Omentin-1 has been shown to be decreased in patients with obesity [21] . Several reports have shown an association between omentin-1 and BMI values [22] . This might be indicative of the role of adiposity in regulating omentin-1 expression.
We also found that serum omentin-1 concentrations were positively correlated with CIMT, an indicator of early atherosclerosis [23] . This might be related to the potential role of omenin-1 in determining insulin sensitivity [24] .
Only body weight and mean CIMT were shown to be independent predictors of serum omentin-1 levels, explaining 10.6% of the total variance according to the multiple regression model (Table 3) . These findings may support the hypothesis that omentin-1 is a potential marker of cardiovascular disease, perhaps providing a link between obesity and atherosclerosis [25] .
Animal studies have indicated a protective role for omentin-1 in cardiovascular endothelium [26] , and observational studies in man have shown that decreased serum omentin-1 concentrations may contribute to development of coronary heart diseases by modulating insulin action [24] .
Omentin-1 may be involved in suppressing bone formation [19] . Nevertheless, none of the bone profile parameters that we measured in this current study were shown to be predictive of serum omentin-1 levels.
In conclusion, serum omentin-1 levels are correlated with CIMT and body weight in postmenopausal women. However, the molecular mechanisms linking bone metabolism and adipose tissue need further elucidation.
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